Oral pharmaceutical composition
AssigneeSigmoid Pharma Limited
InventorIvan Coulter
Life of this patent
Estimating the term…
Abstract
The present application provides a method for treating or preventing Celiac disease. In one embodiment the method comprises administering to a patient in need thereof a composition comprising minicapsules, wherein the minicapsules comprise a steroid in a liquid, semi-solid or solid core, the minicapsules having release profiles to release the steroid in an active form at one or more sites along the gastrointestinal tract, the one or more sites comprising the proximal small intestine beginning at the duodenum and ending at the ileum. In a related embodiment the method comprises administering budesonide to a patient in need thereof in a pre-solubilized drug delivery format.
Claims32
A method for treating Celiac disease, wherein the method is selected from A or B:
- A. a method comprising administering to a patient in need thereof a composition comprising minicapsules, wherein the minicapsules comprise a steroid in a liquid, semi-solid or solid core, the minicapsules having release profiles to release the steroid in an active form at one or more sites along the gastrointestinal tract, the one or more sites comprising the proximal small intestine beginning at the duodenum and ending at the ileum;
- and
- B. a method comprising administering budesonide to a patient in need thereof in a solubilised drug delivery format.
Dependencies are inferred from the claim text.